# PhiFund Ventures

PhiFund Ventures is a Venture Capital based in New York, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2021
- **Assets under management:** Undisclosed
- **Website:** phifundvc.com
- **LinkedIn:** https://www.linkedin.com/company/phifundvc

## Regulatory record

- **Reports private funds:** No

## About

Early-Stage Life Sciences | Accelerating Innovations | Connecting Science with Medical Need | PhiFund focuses on creating and supporting companies that can transform healthcare. We identify academic intellectual property and early stage companies that have the potential to greatly accelerate advances in diagnosis and treatment.

## Sectors

- Digital Health
- Healthcare Services
- Neurology & CNS
- Dermatology & Aesthetics
- Mental Health
- Medical Devices

## People

- Patricia Tolete — Director of Operations
- Michael Jasulavic — Advisor
- Orrin Devinsky, MD — Principal Investigator

## Questions

### How does PhiFund Ventures source its deals?

Deal flow originates heavily from clinical and translational research networks. Orrin Devinsky's position at NYU Langone — whose neurology and neurosurgery programs were ranked #1 by US News & World Report — provides visibility into early-stage projects well before they reach institutional rounds. Patricia Tolete's clinical operations background at Mount Sinai and TrialSpark adds a second sourcing channel through the clinical trial ecosystem.

### Does PhiFund invest in therapeutics, devices, or both?

Both. The portfolio includes small-molecule and biologic therapeutics (Leal Therapeutics, Diatiro), medical devices (Blackrock Neurotech's brain-computer interface), botanical drug candidates (Ajna BioSciences), and platform technologies like Epitor Therapeutics' epigenetic editing tools. This modality-agnostic approach matches deal selection to the science rather than fitting science into a narrow fund mandate.

### What is PhiFund's relationship to HBM Partners?

Michael Jasulavic serves as an advisor to HBM Partners, a healthcare-focused investment fund, while simultaneously sourcing and advising on investments for PhiFund Ventures. The relationship provides PhiFund with connectivity to a broader pool of institutional healthcare investors, though the firms remain legally separate entities with independent investment committees.

### Which stages does PhiFund Ventures target?

PhiFund concentrates on early-stage life sciences: pre-clinical through Series A. Portfolio company descriptions reference proof-of-concept data, pending IND filings, and early-phase clinical trials rather than commercial-stage assets. The firm occasionally participates in later rounds for existing portfolio companies when the science warrants continued support.

## Related profiles

- [PHI](https://altss.com/profile/phi)
- [PHI Industrial](https://altss.com/profile/phi-industrial)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/phifund-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology